Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Functional Neurochemistry of Alzheimers Disease

Author(s): Wieland Gsell, Gerd Jungkunz and Peter Riederer

Volume 10, Issue 3, 2004

Page: [265 - 293] Pages: 29

DOI: 10.2174/1381612043386473

Price: $65

Abstract

A review of neurochemical research on classical neurotransmitters, i.e. acetylcholine, serotonin, noradrenaline, dopamine, glutamate, and GABA in Alzheimers disease is presented. Findings are linked to the information processing system of the human brain to establish a more functional neurochemistry. On this basis, different pharmacotherapeutic strategies are discussed. Our conclusion is that current symptomatic therapy of Alzheimers disease is insufficient. Besides therapy with acetylcholineesterase inhibitors, comedication to act on imbalances between serotonin and noradrenaline on the one site, and dopamine, glutamate and GABA on the other site should should be considered.

Keywords: Neurochemistry, acetylcholineesterase, serotonin, dopamine, glutamate, GABA, noradrenaline


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy